临床前影像市场规模、份额和成长分析（按组件、模式、应用和地区划分）—2026-2033年产业预测

全球临床前影像市场规模预计在 2024 年达到 37.7 亿美元，从 2025 年的 39.5 亿美元成长到 2033 年的 57.5 亿美元，在预测期（2026-2033 年）内复合年增长率为 4.8%。

全球临床前影像市场正蓬勃发展，其主要驱动力是药物研发、分子生物学和转化医学领域对先进研究工具日益增长的需求。该领域对于评估新型候选药物的疗效和安全性、了解疾病进展以及推进个人化医疗至关重要。此外，慢性病、癌症和神经系统疾病发病率的上升也推动了该行业的成长，因为这些疾病需要精准、非侵入性的影像方法来研究动物模型中的疾病机制。近年来，高解析度磁振造影（MRI）、正子断层扫描（PET）、电脑断层扫描（CT）和多模态影像系统等技术的创新，提高了研究人员即时观察生物过程的能力。此外，人工智慧和机器学习在影像分析中的应用，也使得影像解读更加精准。该领域持续成长的资金筹措和合作项目，凸显了临床前研究中对可扩展成像解决方案日益增长的需求。

全球临床前影像市场驱动因素

慢性病、癌症和神经系统疾病的日益增多，推动了人们对精准、非侵入性且创新的临床前成像技术的兴趣。製药和生物製药公司正利用这些先进的影像工具来评估药物疗效、追踪疾病进展并优化治疗策略。此外，对高效、全面的药物研发流程的持续需求，也促使人们增加对高解析度和多模态成像技术的投资。这些因素共同作用，显着影响全球临床前造影市场的格局，相关人员都在寻求提升研发能力和加速有效治疗方法开发的解决方案。

限制全球临床前影像市场的因素

全球临床前影像市场面临诸多限制因素，主要源自于购置和维护先进成像系统所需的高成本。对于开发中国家的小规模实验室、Start-Ups公司和研究机构而言，这笔经济负担尤其沉重。高解析度磁振造影（MRI）、正子断层扫描/电脑断层扫描（PET/CT）和混合成像系统等高阶技术不仅需要大量的初始投资，还需要持续投入资金用于系统校准、软体更新、维护以及耗材等。此外，还需要聘请或培训专业人员来有效操作这些复杂的系统，这进一步增加了营运成本，也为许多机构进入该市场设定了进入门槛。

全球临床前影像市场趋势

全球临床前影像市场正经历显着的发展趋势，而人工智慧 (AI) 和机器学习 (ML) 技术的应用日益广泛是推动这一趋势的关键因素。这些技术的融合透过自动化影像分析、组织分割、生物标记识别和预测建模等方式，显着提升了成像流程，简化了工作流程，减少了人工操作。随着这些先进工具不断提高成像精度并简化复杂成像数据的解读，研究人员能够更有效率地获取更有价值的资讯。 AI 和 ML 对影像能力的持续提升，不仅推动了临床前研究的创新，也加速了各生物医学领域新型治疗方案的研发。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

全球临床前影像市场规模（按组件划分）及复合年增长率（2026-2033 年）

• 硬体系统
• 软体和服务

全球临床前影像市场规模（以影像方式划分）及复合年增长率（2026-2033 年）

• 磁振造影（MRI）
• 正子断层扫描（PET）
• 电脑断层扫描（CT）
• 光学成像
• 超音波影像
• 单光子发射电脑断层扫描（SPECT）
• 多模态成像

全球临床前影像市场规模（按应用及复合年增长率划分）（2026-2033 年）

• 药物发现与开发
• 疾病监测
• 转换医学
• 毒理学研究

全球临床前影像市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Bruker Corporation（USA）
• Revvity, Inc.（USA）
• FUJIFILM VisualSonics Inc.（Canada）
• Mediso Medical Imaging Systems Ltd.（Hungary）
• MR Solutions（UK）
• Aspect Imaging Limited（USA）
• TriFoil Imaging（USA）
• MILabs BV（Netherlands）
• Siemens Healthineers AG（Germany）
• General Electric（GE）HealthCare Technologies Inc.（USA）
• Cubresa Inc.（Canada）
• Berthold Technologies GmbH & Co. KG（Germany）
• Miltenyi Biotec GmbH（Germany）
• Li-Cor Biosciences（USA）
• Sofie（USA）
• Advanced Molecular Vision（UK）
• Vieworks Co., Ltd.（South Korea）
• Kub Technologies（USA）
• Medikors Inc.（South Korea）
• SCANCO Medical AG（Switzerland）

结论与建议

Global Preclinical Imaging Market size was valued at USD 3.77 Billion in 2024 and is poised to grow from USD 3.95 Billion in 2025 to USD 5.75 Billion by 2033, growing at a CAGR of 4.8% during the forecast period (2026-2033).

The global preclinical imaging market is on an upward trajectory, driven by a rising demand for sophisticated research tools in drug discovery, molecular biology, and translational medicine. This sector is crucial for assessing the efficacy and safety of new drug candidates, comprehending disease progression, and advancing personalized therapies. The industry growth is further fueled by the rising incidence of chronic, cancerous, and neurological diseases necessitating precise, non-invasive imaging methods for studying disease mechanisms in animal models. Recent technological innovations, including high-resolution MRI, PET, CT, and multimodal imaging systems, enhance researchers' capabilities to visualize biological processes in real-time. Additionally, the integration of AI and machine learning in imaging analysis is creating more accurate interpretations as funding and collaborations within the sector continue to flourish, highlighting the demand for scalable imaging solutions in preclinical studies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Preclinical Imaging market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Preclinical Imaging Market Segments Analysis

Global Preclinical Imaging Market is segmented by Component, Modality, Application and region. Based on Component, the market is segmented into Hardware Systems and Software & Services. Based on Modality, the market is segmented into Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Computed Tomography (CT), Optical Imaging, Ultrasound Imaging, Single Photon Emission Computed Tomography (SPECT) and Multimodal Imaging. Based on Application, the market is segmented into Drug Discovery & Development, Disease Research, Translational Medicine and Toxicology Studies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Preclinical Imaging Market

The rise in chronic diseases, cancer, and neurological disorders is driving heightened interest in innovative preclinical imaging techniques that offer precision and non-invasiveness. Both pharmaceutical and biopharmaceutical companies are leveraging these advanced imaging tools to assess drug effectiveness, track disease progression, and refine treatment strategies. Additionally, the ongoing demand for efficient and thorough drug discovery processes is propelling investments into high-resolution and multimodal imaging technologies. This confluence of factors is significantly shaping the landscape of the global preclinical imaging market, as stakeholders seek solutions that enhance research capabilities and accelerate the development of effective therapeutics.

Restraints in the Global Preclinical Imaging Market

The Global Preclinical Imaging market faces significant restraints primarily due to the substantial costs involved in acquiring and maintaining advanced imaging systems. This financial burden can be particularly challenging for smaller laboratories, startups, and research institutions in developing countries. High-end technologies like high-resolution MRI, PET/CT, and hybrid imaging systems demand not only a considerable initial investment but also continuous expenses related to system calibration, software updates, maintenance, and necessary consumables. Additionally, the need to hire or train specialized personnel to effectively operate these complex systems further escalates operational expenditures, posing a barrier to entry for many organizations in the market.

Market Trends of the Global Preclinical Imaging Market

The Global Preclinical Imaging market is witnessing a significant trend driven by the rising adoption of artificial intelligence (AI) and machine learning (ML) technologies. This integration enhances imaging processes through automated image analysis, tissue segmentation, biomarker identification, and predictive modeling, streamlining workflows and reducing manual workloads. As these advanced tools improve accuracy and facilitate the interpretation of complex imaging data, researchers are empowered to derive more meaningful insights efficiently. The ongoing enhancement of imaging capabilities through AI and ML not only fosters innovation in preclinical research but also accelerates the development of novel therapeutic solutions across various biomedical fields.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Preclinical Imaging Market Size by Component & CAGR (2026-2033)

• Market Overview
• Hardware Systems
• Software & Services

Global Preclinical Imaging Market Size by Modality & CAGR (2026-2033)

• Market Overview
• Magnetic Resonance Imaging (MRI)
• Positron Emission Tomography (PET)
• Computed Tomography (CT)
• Optical Imaging
• Ultrasound Imaging
• Single Photon Emission Computed Tomography (SPECT)
• Multimodal Imaging

Global Preclinical Imaging Market Size by Application & CAGR (2026-2033)

• Market Overview
• Drug Discovery & Development
• Disease Research
• Translational Medicine
• Toxicology Studies

Global Preclinical Imaging Market Size & CAGR (2026-2033)

• North America (Component, Modality, Application)
  • US
  • Canada
• Europe (Component, Modality, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Component, Modality, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Component, Modality, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Component, Modality, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Bruker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revvity, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FUJIFILM VisualSonics Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mediso Medical Imaging Systems Ltd. (Hungary)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MR Solutions (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aspect Imaging Limited (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TriFoil Imaging (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MILabs B.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• General Electric (GE) HealthCare Technologies Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cubresa Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Berthold Technologies GmbH & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Li-Cor Biosciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sofie (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advanced Molecular Vision (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vieworks Co., Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kub Technologies (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medikors Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SCANCO Medical AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations